BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 11121626)

  • 21. Neoadjuvant interstitial high-dose-rate (HDR) brachytherapy combined with systemic chemotherapy in patients with breast cancer.
    Roddiger SJ; Kolotas C; Filipowicz I; Kurek R; Kuner RP; Martin T; Baltas D; Rogge B; Kontova M; Hoffmann G; Pollow B; Zamboglou N
    Strahlenther Onkol; 2006 Jan; 182(1):22-9. PubMed ID: 16404517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of high-dose-rate brachytherapy alone after lumpectomy in patients with early-stage breast cancer treated with breast-conserving therapy.
    Baglan KL; Martinez AA; Frazier RC; Kini VR; Kestin LL; Chen PY; Edmundson G; Mele E; Jaffray D; Vicini FA
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):1003-11. PubMed ID: 11429228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PDR brachytherapy with flexible implants for interstitial boost after breast-conserving surgery and external beam radiation therapy.
    Fritz P; Berns C; Anton HW; Hensley F; Assman J; Flentje M; von Fournier D; Wannenmacher M
    Radiother Oncol; 1997 Oct; 45(1):23-32. PubMed ID: 9364628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study.
    Benitez PR; Streeter O; Vicini F; Mehta V; Quiet C; Kuske R; Hayes MK; Arthur D; Kuerer H; Freedman G; Keisch M; Dipetrillo T; Khan D; Hudes R
    Am J Surg; 2006 Oct; 192(4):427-33. PubMed ID: 16978943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Weekly concomitant boost in adjuvant radiotherapy for patients with early breast cancer: preliminary results on feasibility.
    Corvò R; Giudici S; Maggio F; Bevegni M; Sampietro C; Lucido MR; Orsatti M
    Tumori; 2008; 94(5):706-11. PubMed ID: 19112945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patterns of breast recurrence in a pilot study of brachytherapy confined to the lumpectomy site for early breast cancer with six years' minimum follow-up.
    Perera F; Yu E; Engel J; Holliday R; Scott L; Chisela F; Venkatesan V
    Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1239-46. PubMed ID: 14630257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term cosmetic results and toxicity after accelerated partial-breast irradiation: a method of radiation delivery by interstitial brachytherapy for the treatment of early-stage breast carcinoma.
    Chen PY; Vicini FA; Benitez P; Kestin LL; Wallace M; Mitchell C; Pettinga J; Martinez AA
    Cancer; 2006 Mar; 106(5):991-9. PubMed ID: 16421922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial.
    Strnad V; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Gutierrez Miguelez C; Slampa P; Allgäuer M; Lössl K; Polat B; Kovács G; Fischedick AR; Wendt TG; Fietkau R; Hindemith M; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Pötter R; Gall C; Malzer M; Uter W; Polgár C;
    Lancet; 2016 Jan; 387(10015):229-38. PubMed ID: 26494415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preservation of cosmesis with low complication risk after conservative surgery and radiotherapy for ductal carcinoma in situ of the breast.
    Mills JM; Schultz DJ; Solin LJ
    Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):637-41. PubMed ID: 9336143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Irradiation of the tumor bed alone after lumpectomy in selected patients with early-stage breast cancer treated with breast conserving therapy.
    Vicini F; Kini VR; Chen P; Horwitz E; Gustafson G; Benitez P; Edmundson G; Goldstein N; McCarthy K; Martinez A
    J Surg Oncol; 1999 Jan; 70(1):33-40. PubMed ID: 9989418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toxicity and cosmetic outcome of hypofractionated whole-breast radiotherapy: predictive clinical and dosimetric factors.
    Ciammella P; Podgornii A; Galeandro M; Micera R; Ramundo D; Palmieri T; Cagni E; Iotti C
    Radiat Oncol; 2014 Apr; 9():97. PubMed ID: 24762173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraoperative radiotherapy given as a boost for early breast cancer: long-term clinical and cosmetic results.
    Lemanski C; Azria D; Thezenas S; Gutowski M; Saint-Aubert B; Rouanet P; Fenoglietto P; Ailleres N; Dubois JB
    Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1410-5. PubMed ID: 16442241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dose-volume analysis of radiotherapy for T1N0 invasive breast cancer treated by local excision and partial breast irradiation by low-dose-rate interstitial implant.
    Lawenda BD; Taghian AG; Kachnic LA; Hamdi H; Smith BL; Gadd MA; Mauceri T; Powell SN
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):671-80. PubMed ID: 12788172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ductal carcinoma in situ detected in the mammographic era: an analysis of clinical, pathologic, and treatment-related factors affecting outcome with breast-conserving therapy.
    Vicini FA; Lacerna MD; Goldstein NS; Horwitz EM; Dmuchowski CF; White JR; Gustafson GS; Ingold JA; Martinez AA
    Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):627-35. PubMed ID: 9336142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. International comparison of cosmetic outcomes of breast conserving surgery and radiation therapy for women with ductal carcinoma in situ of the breast.
    Olivotto IA; Link E; Phillips C; Whelan TJ; Bryant G; Kunkler IH; Westenberg AH; Purohit K; Ahern V; Graham PH; Akra M; McArdle O; Ludbrook JJ; Harvey JA; Maduro JH; Kirkove C; Gruber G; Martin JD; Campbell ID; Delaney GP; Chua BH;
    Radiother Oncol; 2020 Jan; 142():180-185. PubMed ID: 31431385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypofractionated Versus Standard Fractionated Radiotherapy in Patients With Early Breast Cancer or Ductal Carcinoma In Situ in a Randomized Phase III Trial: The DBCG HYPO Trial.
    Offersen BV; Alsner J; Nielsen HM; Jakobsen EH; Nielsen MH; Krause M; Stenbygaard L; Mjaaland I; Schreiber A; Kasti UM; Overgaard J;
    J Clin Oncol; 2020 Nov; 38(31):3615-3625. PubMed ID: 32910709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brachytherapy or electron beam boost in conservation therapy of carcinoma of the breast: a nonrandomized comparison.
    Perez CA; Taylor ME; Halverson K; Garcia D; Kuske RR; Lockett MA
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):995-1007. PubMed ID: 8600112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Partial breast irradiation with interstitial 60CO brachytherapy results in frequent grade 3 or 4 toxicity. Evidence based on a 12-year follow-up of 70 patients.
    Póti Z; Nemeskéri C; Fekésházy A; Sáfrány G; Bajzik G; Nagy ZP; Bidlek M; Sinkovics I; Udvarhelyi N; Liszkay G; Repa I; Galuska L; Trón L; Mayer A; Esik O
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1022-33. PubMed ID: 15001241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single fraction of accelerated partial breast irradiation in the elderly: early clinical outcome.
    Kinj R; Chand ME; Gal J; Gautier M; Montagné L; Lam Cham Kee D; Hannoun-Lévi JM
    Radiat Oncol; 2018 Sep; 13(1):174. PubMed ID: 30208914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast-conservative surgery with close or positive margins: can the breast be preserved with high-dose-rate brachytherapy boost?
    Guinot JL; Roldan S; Maroñas M; Tortajada I; Carrascosa M; Chust ML; Estornell M; Mengual JL; Arribas L
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1381-7. PubMed ID: 17418974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.